Profound Medical (NASDAQ:PROF) Cut to Hold at Jefferies Financial Group
Jefferies Financial Group cut shares of Profound Medical (NASDAQ:PROF – Get Rating) from a buy rating to a hold rating in a report published on Tuesday, Marketbeat.com reports. The brokerage currently has $10.00 target price on the stock, up from their prior target price of $5.50. Jefferies Financial Group also issued estimates for Profound Medical’s […]